01.002 RWE GS Aug 2022 B 11-8-22

Synapse and FDA collaborate to swiftly generate real-world data (RWD) in COVID-19 patients with cancer

The collaboration is already yielding useful results and aims to tackle the following:
  • Investigating methods to derive RWD from multiple sources including electronic health records, registries and molecular data;
  • Enhancing understanding of how patients respond to therapies outside of clinical trials to improve care and outcomes;
  • Understanding the impact of COVID-19 on cancer care.
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at